Doodnauth Andrew V, Zhou Jordan I, Patel Krunal H, Yacoub Fadi, Dunkley Julian
Internal Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, USA.
Internal Medicine, State University of New York (SUNY) Downstate College of Medicine, Brooklyn, USA.
Cureus. 2021 Jun 20;13(6):e15783. doi: 10.7759/cureus.15783.
Life-threatening arrhythmias have been variably reported among patients hospitalized for COVID-19 infection. Sudden cardiac arrest (SCA) in COVID-19 patients is an alarming concern for clinicians. Multiple factors play an important role in the development of SCA in patients with severe systemic illness. We describe a case of COVID-19 in a New York City hospital in Spring 2020 that rapidly developed SCA and, before discharge, received a single lead transvenous implantable cardioverter defibrillator for secondary prevention. This case highlights the use of an automated implantable cardioverter-defibrillator as a secondary preventive measure irrespective of left ventricular function as a means of preventing recurrence of SCA as a sequela of COVID-19.
在因感染新冠病毒而住院的患者中，危及生命的心律失常报告情况不一。新冠病毒患者发生心搏骤停（SCA）是临床医生极为担忧的问题。多种因素在重症全身性疾病患者发生SCA的过程中起重要作用。我们描述了2020年春季纽约市一家医院收治的一例新冠病毒患者，该患者迅速发生SCA，并在出院前接受了单腔静脉植入式心脏复律除颤器用于二级预防。该病例凸显了使用植入式自动心脏复律除颤器作为二级预防措施，无论左心室功能如何，以此预防作为新冠病毒后遗症的心搏骤停复发。
